Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hagar, Banai"'
Autor:
Yanai, Henit *, *, Levine, Arie *, Hirsch, Ayal, Boneh, Rotem Sigall, Kopylov, Uri, Eran, Hagar Banai, Cohen, Nathaniel A, Ron, Yulia, Goren, Idan, Leibovitzh, Haim, Wardi, Joram, Zittan, Eran, Ziv-Baran, Tomer, Abramas, Lee, Fliss-Isakov, Naomi, Raykhel, Barbara, Gik, Tamar Pfeffer, Dotan, Iris, Maharshak, Nitsan
Publikováno v:
In The Lancet Gastroenterology & Hepatology January 2022 7(1):49-59
Autor:
Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Yelena Broitman, Haim Ben Zvi, Tsachi-Tsadok Perets, Rami Eliakim, Revital Barkan, Sophy Goren, Dani Cohen, Iris Dotan
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1263 (2023)
Vaccines are pivotal for control of the coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBDs) treated with antitumor necrosis factor (TNF)-α have lower serologic response after two COVID-19 vaccine doses. Data reg
Externí odkaz:
https://doaj.org/article/9af7d59e6bff4e7b8f461f8cd2945422
Autor:
Henit Yanai, Hadar Amir Barak, Jacob E Ollech, Irit Avni Biron, Idan Goren, Yifat Snir, Hagar Banai Eran, Yelena Broitman, Maya Aharoni Golan, Elena Didkovsky, Iris Amitay-Laish, Ayelet Ollech, Emmilia Hodak, Iris Dotan, Lev Pavlovsky
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background and Aims: Skin eruptions are prevalent among patients with inflammatory bowel diseases (IBD), often associated with therapies and frequently leading to dermatological consults and treatment interruptions. We aimed to assess the impact of j
Externí odkaz:
https://doaj.org/article/88b32f4454734962ae309656aa9a48f8
Autor:
Keren Masha Rabinowitz, Michal Navon, Hadar Edelman-Klapper, Eran Zittan, Ariella Bar-Gil Shitrit, Idan Goren, Irit Avni-Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit Yanai, Yifat Snir, Maor H. Pauker, Adi Friedenberg, Adva Levy-Barda, Arie Segal, Yelena Broitman, Eran Maoz, Baruch Ovadia, Maya Aharoni Golan, Eyal Shachar, Shomron Ben-Horin, Nitsan Maharshak, Michal Mor, Haim Ben Zvi, Rami Eliakim, Revital Barkan, Tali Sharar-Fischler, Sophy Goren, Noy Krugliak, Edward Pichinuk, Michael Mor, Michal Werbner, Joel Alter, Hanan Abu-Taha, Kawsar Kaboub, Moshe Dessau, Meital Gal-Tanamy, Dani Cohen, Natalia T. Freund, Iris Dotan, on behalf of the Responses to COVID-19 Vaccine Israeli IBD Group
Publikováno v:
Vaccines, Vol 10, Iss 8, p 1186 (2022)
Patients with inflammatory bowel disease (IBD) treated with anti-tumor-necrosis factor-alpha (TNFα) exhibited lower serologic responses one-month following the second dose of the COVID-19 BNT162b2 vaccine compared to those not treated with anti-TNF
Externí odkaz:
https://doaj.org/article/002599bbb4e74664a74f8cb9e8c3051d
Autor:
Lev Lichtenstein, Benjamin Koslowsky, Ami Ben Ya’acov, Irit Avni-Biron, Baruch Ovadia, Ofer Ben-Bassat, Timna Naftali, Uri Kopylov, Yael Haberman, Hagar Banai Eran, Rami Eliakim, Adi Lahat-Zok, Ayal Hirsch, Eran Zittan, Nitsan Maharshak, Matti Waterman, Eran Israeli, Idan Goren, Jacob E. Ollech, Henit Yanai, Bella Ungar, Benjamin Avidan, Dana Ben Hur, Bernardo Melamud, Ori Segol, Zippora Shalem, Iris Dotan, Selwyn H. Odes, Shomron Ben-Horin, Yf’at Snir, Yael Milgrom, Efrat Broide, Eran Goldin, Shmuel Delgado, Yulia Ron, Nathaniel Aviv Cohen, Eran Maoz, Maya Zborovsky, Safwat Odeh, Naim Abu Freha, Eyal Shachar, Yehuda Chowers, Tal Engel, Hila Reiss-Mintz, Arie Segal, Adar Zinger, Ariella Bar-Gil Shitrit
Publikováno v:
Vaccines, Vol 10, Iss 3, p 376 (2022)
Background: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, immune-mediated inflammatory bowel diseases (IBD) affecting millions of people worldwide. IBD therapies, designed for continuous immune suppression, often render patients mor
Externí odkaz:
https://doaj.org/article/eca69cf35e7040a98fb236c6175f11ed
Autor:
Ollech, Tom Konikoff, Henit Yanai, Dror Libchik, Irit Avni-Biron, Yifat Snir, Hagar Banai, Yelena Broytman, Iris Dotan, Jacob E.
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4488
Background and Aim: Drug sustainability (DS) is a surrogate marker for treatment efficacy. We aimed to compare the DS of two main biologics used to treat moderate-to-severe ulcerative colitis (UC), infliximab (IFX) and vedolizumab (VDZ), in a real-wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::749f42c342eed254e8b471984b5f11ce
Autor:
Jacob E, Ollech, Henit, Yanai, Irit, Avni-Biron, Yifat, Snir, Hagar, Banai, Revital, Barkan, Lihi, Godny, Nir, Wasserberg, Ian, White, Iris, Dotan
Publikováno v:
American Journal of Gastroenterology. 118:367-370
Whether fecal calprotectin (FC) and quality of life (QoL) questionnaires reflect change in disease activity in patients with a J-pouch is unknown.Patients with acute pouchitis were prospectively treated with a 2-week course of antibiotics. The full P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fa09fdeeac15929d51af53400d42486
https://doi.org/10.14309/ajg.0000000000002038
https://doi.org/10.14309/ajg.0000000000002038
Autor:
Yanai, Irit Avni Biron, Lior Hayat, Jacob E. Ollech, Hagar Banai-Eran, Bar Narkis, Ohad Houri, Maor H. Pauker, Vardit Shay, Iris Dotan, Eran Hadar, Henit
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 12; Pages: 4120
Background: Inflammatory bowel disease (IBD) can have an impact on pregnancy outcomes due to the effect of the disease activity and medication use. This study aimed to evaluate the pregnancy outcomes in IBD patients treated at a multidisciplinary cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::11ee0b63fd960df6e34d9a91e0954840
Autor:
Lev Lichtenstein, Eran Maoz, Sophy Goren, Adva Levy-Barda, Eyal Shachar, Maya Aharoni Golan, Michal Navon, Maor H. Pauker, Baruch Ovadia, Natalia T. Freund, Arie Segal, Hadar Edelman-Klapper, Rami Eliakim, Joel Alter, Jacob E. Ollech, Hagar Banai-Eran, Keren M. Rabinowitz, Haim Ben Zvi, Revital Barkan, Michal Werbner, Idan Goren, Ariella Bar-Gil Shitrit, Yelena Broitman, Henit Yanai, Tsachi-Tsadok Perets, Yifat Snir, Noy Krugliak, Shomron Ben-Horin, Dani Cohen, Meital Gal-Tanamy, Adi Friedenberg, Irit Avni-Biron, Moshe Dessau, Iris Dotan, Eran Zittan
Publikováno v:
Gastroenterology
Background Patients with inflammatory bowel diseases (IBD), specifically those treated with anti-tumor-necrosis-factor (TNF)α biologics are at high risk for vaccine preventable infections. Their ability to mount adequate vaccine responses is unclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e0bc569a9da2648440d1ee93a77eb9d
https://doi.org/10.1053/j.gastro.2021.10.029
https://doi.org/10.1053/j.gastro.2021.10.029
Autor:
Naomi Fliss-Isakov, Lee Abramas, Tomer Ziv-Baran, Nathaniel A. Cohen, Iris Dotan, Arie Levine, Yulia Ron, Tamar Pfeffer Gik, Eran Zittan, H Leibovitzh, Joram Wardi, Uri Kopylov, Hagar Banai Eran, Ayal Hirsch, Rotem Sigall Boneh, Barbara Raykhel, Henit Yanai, Nitsan Maharshak, Idan Goren
Publikováno v:
The Lancet Gastroenterology & Hepatology. 7:49-59
Summary Background The Crohn's disease exclusion diet (CDED) with partial enteral nutrition is effective for induction of remission in children with mild-to-moderate Crohn's disease. We aimed to assess the CDED in adults with Crohn's disease. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5e16b9ecb652509572e663437967af8
https://doi.org/10.1016/s2468-1253(21)00299-5
https://doi.org/10.1016/s2468-1253(21)00299-5